p34cdc2-mediated phosphorylation at T124 inhibits nuclear import of SV-40 T antigen proteins. 1991

D A Jans, and M J Ackermann, and J R Bischoff, and D H Beach, and R Peters
Max-Planck-Institut für Biophysik, Frankfurt, Germany.

The nuclear import of transcription regulatory proteins appears to be used by the cell to trigger transitions in cell cycle, morphogenesis, and transformation. We have previously observed that the rate at which SV-40 T antigen fusion proteins containing a functional nuclear localization sequence (NLS; residues 126-132) are imported into the nucleus is enhanced in the presence of the casein kinase II (CK-II) site S111/112. In this study purified p34cdc2 kinase was used to phosphorylate T antigen proteins specifically at T124 and kinetic measurements at the single-cell level performed to assess its effect on nuclear protein import. T124 phosphorylation, which could be functionally simulated by a T-to-D124 substitution, was found to reduce the maximal extent of nuclear accumulation whilst negligibly affecting the import rate. The inhibition of nuclear import depended on the stoichiometry of phosphorylation. T124 and S111/112 could be phosphorylated independently of one another. Two alternative mechanisms were considered to explain the inhibition of nuclear import by T124 phosphorylation: inactivation of the NLS and cytoplasmic retention, respectively. Furthermore, we speculate that in vivo T124 phosphorylation may regulate the small but functionally significant amount of cytoplasmic SV-40 T antigen. A sequence comparison showed that many transcription regulatory proteins contain domains comprising potential CK-II-sites, cdc2-sites, and NLS. This raises the possibility that the three elements represent a functional unit regulating nuclear protein import.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000957 Antigens, Viral, Tumor Those proteins recognized by antibodies from serum of animals bearing tumors induced by viruses; these proteins are presumably coded for by the nucleic acids of the same viruses that caused the neoplastic transformation. Antigens, Neoplasm, Viral,Neoplasm Antigens, Viral,T Antigens,Tumor Antigens, Viral,Viral Tumor Antigens,Virus Transforming Antigens,Large T Antigen,Large T-Antigen,Small T Antigen,Small T-Antigen,T Antigen,T-Antigen,Viral T Antigens,Antigen, Large T,Antigen, Small T,Antigen, T,Antigens, T,Antigens, Viral Neoplasm,Antigens, Viral T,Antigens, Viral Tumor,Antigens, Virus Transforming,T Antigen, Large,T Antigen, Small,T Antigens, Viral,T-Antigen, Large,T-Antigen, Small,Transforming Antigens, Virus,Viral Neoplasm Antigens

Related Publications

D A Jans, and M J Ackermann, and J R Bischoff, and D H Beach, and R Peters
April 1983, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
D A Jans, and M J Ackermann, and J R Bischoff, and D H Beach, and R Peters
November 1993, Oncogene,
D A Jans, and M J Ackermann, and J R Bischoff, and D H Beach, and R Peters
January 2010, Bioorganicheskaia khimiia,
D A Jans, and M J Ackermann, and J R Bischoff, and D H Beach, and R Peters
January 2009, Chemical biology & drug design,
D A Jans, and M J Ackermann, and J R Bischoff, and D H Beach, and R Peters
May 1967, Virology,
D A Jans, and M J Ackermann, and J R Bischoff, and D H Beach, and R Peters
November 1996, FEBS letters,
D A Jans, and M J Ackermann, and J R Bischoff, and D H Beach, and R Peters
September 1997, The Journal of cell biology,
D A Jans, and M J Ackermann, and J R Bischoff, and D H Beach, and R Peters
October 2002, Molecular and cellular biology,
D A Jans, and M J Ackermann, and J R Bischoff, and D H Beach, and R Peters
June 1987, Experimental cell research,
D A Jans, and M J Ackermann, and J R Bischoff, and D H Beach, and R Peters
January 1975, Biulleten' eksperimental'noi biologii i meditsiny,
Copied contents to your clipboard!